Maria-Agustina
Rossi
a,
Veronica
Martinez
b,
Philip
Hinchliffe
c,
Maria F.
Mojica
def,
Valerie
Castillo
b,
Diego M.
Moreno
gj,
Ryan
Smith
c,
Brad
Spellberg
h,
George L.
Drusano
i,
Claudia
Banchio
aj,
Robert A.
Bonomo
eklm,
James
Spencer
c,
Alejandro J.
Vila
*aj and
Graciela
Mahler
*b
aInstituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Ocampo and Esmeralda, S2002LRK Rosario, Argentina. E-mail: vila@ibr-conicet.gov.ar
bLaboratorio de Química Farmacéutica, Departamento de Química Orgánica, Facultad de Química, Universidad de la República (UdelaR), Avda. General Flores 2124, CC1157, Montevideo, Uruguay. E-mail: gmahler@fq.edu.uy
cSchool of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK
dInfectious Diseases Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
eResearch Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA
fGrupo de Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque, Bogotá, DC, Colombia
gInstituto de Química de Rosario (IQUIR, CONICET-UNR), Suipacha 570, S2002LRK Rosario, Argentina
hLos Angeles County and University of Southern California (LAC + USC) Medical Center, Los Angeles, CA, USA
iCenter for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA
jFacultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, S2002LRK Rosario, Argentina
kDepartments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USA
lMedical Service, GRECC, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA
mCWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USA
First published on 15th August 2023
Correction for ‘2-Mercaptomethyl-thiazolidines use conserved aromatic–S interactions to achieve broad-range inhibition of metallo-β-lactamases’ by Maria-Agustina Rossi et al., Chem. Sci., 2021, 12, 2898–2908, https://doi.org/10.1039/D0SC05172A.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2023 |